Losses up 86 per cent as Telix launches flagship drug
MELBOURNE: Revenues at cancer fighter Telix Pharmaceuticals have jumped 46 per cent to $7.6 million
MELBOURNE: Revenues at cancer fighter Telix Pharmaceuticals have jumped 46 per cent to $7.6 million